High prevalence of suspected HIV-associated dementia in adult Malawian HIV patients

International Journal of STD and AIDS

Volumn 21, Issue 5, 2010, Pages 356-358

  Patel, V N ^a   Mungwira, R G ^a   Tarumbiswa, T F ^a   Heikinheimo, T ^a   Van Oosterhout, J J ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Africa; Dementia; Highly active antiretroviral therapy; Human immunodeficiency virus; Malawi

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; EDUCATIONAL STATUS; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL HIV DEMENTIA SCALE; MAJOR CLINICAL STUDY; MALAWI; MALE; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SCREENING TEST; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DEMENTIA; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HUMANS; MALAWI; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK FACTORS; SEX FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 77952852693     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.009554     Document Type: Article

References (15)

1. Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007;27:86-92 (Pubitemid 46239043)
2. Sacktor N, Nakasujja N, Robertson K, Clifford DB. HIV-associated cognitive impairment in sub-Saharan Africa - the potential effect of clade diversity. Nat Clin Pract Neurol 2007;8:436-443 (Pubitemid 47202500)
3. Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005;19:1367-1374 (Pubitemid 41800672)
4. Clifford DB, Mitike MT, Mekonnen Y, et al. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol 2007;13:67-72 (Pubitemid 46510146)
5. Njamnshi AK, Djientcheu Vde P, Fonsah JY, et al. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon. J AIDS 2008;49:393-397
6. The National AIDS Commission. The National Response to HIV and AIDS. Lilongwe: National AIDS Commission, 2007
7. HIV Unit, Ministry of Health, Lilongwe, Malawi 2009. ART Public and Private Sector Report 2008. www.hivunitmohmw.org/uploads/Main/ ART%20Public%20and%20Private%20Sector%202008%20 (last accessed 29 April 2010)
8. Wong MH, Robertson K, Nakasujja N, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 2007;68:350-355 (Pubitemid 46184210)
9. Njamnshi AK, Bissek AC, Ongolo-Zogo P, et al. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci 2009;285:149-153
10. Sacktor N, Nakasujja N, Skolasky R, et al. Antiretroviral therapy improves cognitive impairment in HIV positive individuals in sub Saharan Africa. Neurology 2006;67:311-314 (Pubitemid 44305421)
11. Chen SC, Yu JK, Harries AD, et al. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Trop Med Int Health 2008;13:513-519
12. Sacktor N, Nakasujja N, Skolasky RL, et al. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 2009;49:780-786
13. Hosseinipour MC, van Oosterhout JJG, Weigel R, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS 2009;9:1127-1134
14. Kaul M. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr Opin Neurol 2009;22:315-320
15. Cysique LAJ, Maruff P, Brew BJ. Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 2004;61:1699-1704